Literature DB >> 22773956

14-3-3 proteins in neurological disorders.

Molly Foote1, Yi Zhou.   

Abstract

14-3-3 proteins were originally discovered as a family of proteins that are highly expressed in the brain. Through interactions with a multitude of binding partners, 14-3-3 proteins impact many aspects of brain function including neural signaling, neuronal development and neuroprotection. Although much remains to be learned and understood, 14-3-3 proteins have been implicated in a variety of neurological disorders based on evidence from both clinical and laboratory studies. Here we will review previous and more recent research that has helped us understand the roles of 14-3-3 proteins in both neurodegenerative and neuropsychiatric diseases.

Entities:  

Keywords:  14-3-3; neurodegenerative diseases; neurodevelopment; neuropsychiatric diseases

Year:  2012        PMID: 22773956      PMCID: PMC3388734     

Source DB:  PubMed          Journal:  Int J Biochem Mol Biol        ISSN: 2152-4114


  112 in total

1.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.

Authors:  C Y Peng; P R Graves; R S Thoma; Z Wu; A S Shaw; H Piwnica-Worms
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 2.  14-3-3 proteins in the nervous system.

Authors:  Daniela Berg; Carsten Holzmann; Olaf Riess
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

3.  DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1.

Authors:  Shinichiro Taya; Tomoyasu Shinoda; Daisuke Tsuboi; Junko Asaki; Kumiko Nagai; Takao Hikita; Setsuko Kuroda; Keisuke Kuroda; Mariko Shimizu; Shinji Hirotsune; Akihiro Iwamatsu; Kozo Kaibuchi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

4.  Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Authors:  J Wiltfang; M Otto; H C Baxter; M Bodemer; P Steinacker; E Bahn; I Zerr; J Kornhuber; H A Kretzschmar; S Poser; E Rüther; A Aitken
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.

Authors:  A J Muslin; J W Tanner; P M Allen; A S Shaw
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

6.  14-3-3 proteins on the MAP.

Authors:  A Aitken
Journal:  Trends Biochem Sci       Date:  1995-03       Impact factor: 13.807

7.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

8.  A new 17p13.3 microduplication including the PAFAH1B1 and YWHAE genes resulting from an unbalanced X;17 translocation.

Authors:  Capucine Hyon; Sandrine Marlin; Sandra Chantot-Bastaraud; Philippe Mabboux; Marie-Paule Beaujard; Essam Al Ageeli; Marie-Paule Vazquez; Arnaud Picard; Jean-Pierre Siffroi; Marie-France Portnoï
Journal:  Eur J Med Genet       Date:  2010-12-31       Impact factor: 2.708

9.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.

Authors:  N Ostrerova; L Petrucelli; M Farrer; N Mehta; P Choi; J Hardy; B Wolozin
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

10.  Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment.

Authors:  S C Sreenath Nagamani; F Zhang; O A Shchelochkov; W Bi; Z Ou; F Scaglia; F J Probst; M Shinawi; C Eng; J V Hunter; S Sparagana; E Lagoe; C-T Fong; M Pearson; M Doco-Fenzy; E Landais; M Mozelle; A C Chinault; A Patel; C A Bacino; T Sahoo; S H Kang; S W Cheung; J R Lupski; P Stankiewicz
Journal:  J Med Genet       Date:  2009-07-06       Impact factor: 6.318

View more
  71 in total

Review 1.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

2.  Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations.

Authors:  C Toma; B Torrico; A Hervás; R Valdés-Mas; A Tristán-Noguero; V Padillo; M Maristany; M Salgado; C Arenas; X S Puente; M Bayés; B Cormand
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 3.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

4.  Modulation of GluK2a subunit-containing kainate receptors by 14-3-3 proteins.

Authors:  Changcheng Sun; Haifa Qiao; Qin Zhou; Yan Wang; Yuying Wu; Yi Zhou; Yong Li
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

5.  The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder.

Authors:  Haiyin Li; Ping Su; Terence Ky Lai; Anlong Jiang; Jing Liu; Dongxu Zhai; Charlie Tg Campbell; Frankie Hf Lee; WeiDong Yong; Suvercha Pasricha; Shupeng Li; Albert Hc Wong; Kerry J Ressler; Fang Liu
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

6.  Changes in Brain 14-3-3 Proteins in Response to Insulin Resistance Induced by a High Palatable Diet.

Authors:  Hugo Bock; Aline Rigon Zimmer; Eduardo Rigon Zimmer; Diogo Onofre Gomes de Souza; Luis Valmor Cruz Portela; Maria Luiza Saraiva-Pereira
Journal:  Mol Neurobiol       Date:  2014-10-04       Impact factor: 5.590

7.  Differential expression of serum proteins in rats subchronically exposed to arsenic identified by iTRAQ-based proteomic technology-14-3-3 ζ protein to serve as a potential biomarker.

Authors:  Jin Hui Zhang; Ying Li; Xuan Bo Song; Xiao Hong Ji; Hong Na Sun; Hui Wang; Song Bin Fu; Li Jun Zhao; Dian Jun Sun
Journal:  Toxicol Res (Camb)       Date:  2016-02-01       Impact factor: 3.524

8.  High-throughput endogenous measurement of S-nitrosylation in Alzheimer's disease using oxidized cysteine-selective cPILOT.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Analyst       Date:  2016-05-06       Impact factor: 4.616

9.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

Review 10.  14-3-3 and aggresome formation: implications in neurodegenerative diseases.

Authors:  Baohui Jia; Yuying Wu; Yi Zhou
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.